You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
COVID-19 Resource Center


Q1 Report 2008

Q1 Report 2008

Reporting period January – March

• Orders received increased by 25% to SEK 4,673 million (3,737)
• Net sales increased by 20.3% to SEK 4,107 million (3,415)
• Profit before tax rose by 29% to SEK 369 million (286)
• Net profit increased by 31% to SEK 266 million (203)
• Earnings per share increased by 29.7% to SEK 1.31 (1.01)
• EBITA before restructuring rose by 36.7% to SEK 655 million (479)
• Acquisition of Boston Scientific’s cardiac and vascular surgery divisions
• Continued strong profit forecasts for the year